High-efficacy active cosmetic lines manufactured to ISO 22716 standards, pre-stabilized and ready for custom branding and global shipment.
The intimate wellness and targeted private care sector has shifted rapidly from commoditized hygiene into specialized bio-clinical cosmeceuticals.
Modern formulations bypass aggressive surfactants. Clinical private care mandates a focus on microecological balance, utilizing bio-fermented postbiotics, prebiotics, and lactobacillus extracts to reinforce physiological epithelial protection without disrupting vaginal or skin pH buffers.
With increasing regulatory scrutiny across Europe (CPNP) and North America (MoCRA), consumers expect fragrance-free, paraben-free, hormone-free, and hypoallergenic intimacy products tested stringently against irritation indices.
Contemporary buyers identify with discrete, elevated packaging aesthetics. Moving away from medicinal formats, OEM/ODM programs require ergonomic airless delivery systems, bespoke pumps, and minimalist pharmaceutical tubes designed for direct-to-consumer (DTC) ecosystems.
Product customization requires adjusting viscosities, active payloads, and stabilization agents to survive local environmental pressures and socio-cultural habits.
Formulated specifically for Southeast Asian and Latin American markets where hyperhidrosis, friction-induced darkening, and anaerobic bacterial overgrowth represent prevalent issues. Our OEM solutions emphasize non-greasy, fast-absorbing antibacterial emulsions enriched with botanical calmers.
Designed for high-latitude North American, Central Asian, and European winter markets. These intimate lotions and restoring balms deploy multi-molecular-weight hyaluronic acids and biomimetic ceramides to preserve dermal elasticity and prevent dryness-induced pruritus.
Ultra-mild medical aesthetic support catering to postpartum recovery or laser depilation aftercare. Formulations require zero-sensitization carrier matrices and are developed in sterile cleanrooms matching pharmaceutical ISO standards.
Leveraging the world’s most comprehensive cosmetic clusters in Huadu, Guangzhou, to deliver rapid R&D cycles, raw material verticalization, and resilient bulk production.
Operating two dedicated production centers—Guangzhou Aoyan Cosmetics Co., Ltd. and Guangzhou Xinzimei Cosmetics Co., Ltd. Clients contract directly with manufacturing leadership, ensuring cost transparency, real-time formula adjustments, and immediate batch tracking.
From custom mold fabrication to specialized vacuum pump dispensers and screen printing, all secondary components are sourced within a 50km radius. This localized industrial consolidation reduces sampling turnaround to under 5 business days.
Our emulsification and vacuum compounding suites accommodate flexible batch runs—from responsive pilot launches (ideal for boutique brands assessing target demand) up to multimillion-unit automated continuous output for international retail chains.
Our in-house R&D operates on a continuous innovation trajectory to stay ahead of international clean beauty directives and biotech delivery breakthroughs.
Protecting delicate bio-actives, functional peptides, and lipid-soluble vitamins inside nano-carriers, releasing therapeutic agents steadily across a 12-hour window.
Replacing controversial broad-spectrum biocides with plant-derived organic acid multi-functional complexes (e.g., p-anisic acid, caprylyl glycol fractions).
Synthesizing specific fermentation filtrates that competitively exclude pathogenic strains (such as Candida albicans) while fostering healthy mucosal flora.
Accelerating PCR (Post-Consumer Recycled) packaging, ocean-bound plastic recovery, and marine-degradable bio-polymers to satisfy global ESG mandates.
We eliminate regulatory friction. Our global safety officers prepare market-specific registration dossiers concurrently with primary manufacturing.
Complete preparation of Cosmetic Product Safety Reports (CPSR Part A & B) vetted by toxicologists, Product Information Files (PIF), and direct notification through the Cosmetic Product Notification Portal (CPNP).
Strict compliance under the Modernization of Cosmetics Regulation Act (MoCRA), covering facility establishment registration, product listing, safety substantiation records, and cGMP compliance data.
Issuance of Certificates of Free Sale (CFS), SASO/SABER registration for Saudi Arabia, Halal raw-material trace reports, and ASEAN Cosmetic Directive (ACD) documentation for fast regional release.
Everything prospective brands, pharmaceutical retailers, and venture distributors need to know regarding private care manufacturing contracts.
Expand your brand footprint with clinically paired formulations ranging from peptide repair systems to gentle daily barrier defenses.
